LBA3_PR An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683-Reference-Cited by-同舟云学术

LBA3_PR An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683

Published:2020-09 Issue: Volume:31 Page:S1178
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Le Pechoux C.,Pourel N.,Barlesi F.,Faivre-Finn C.,Lerouge D.,Zalcman G.,Antoni D.,Lamezec B.,Nestle U.,Boisselier P.,Thillays F.,Paumier A.,Dansin E.,Peignaux K.,Madelaine J.,Pichon E.,Larrouy A.,Riesterer O.,Lavole A.,Bardet A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neue radioonkologische Therapiekonzepte beim nicht metastasierten Lungenkarzinom;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2024-08

2. Dosimetric and NTCP advantages of robust proton therapy over robust VMAT for Stage III NSCLC in the immunotherapy era;Physica Medica;2024-07

3. Postoperative ctDNA in indicating the recurrence risk and monitoring the effect of adjuvant therapy in surgical non‐small cell lung cancer;Thoracic Cancer;2024-02-26

4. Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs;Journal of Comparative Effectiveness Research;2023-11

5. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms;Pneumologie;2023-10